Ravi Manoharan (M Ravi)

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 3

Top Topics

Signaling Pathway

Tyrosine Kinase

Breast Cancer Cells

Bioinformatics Analysis

Top Venues

Oxidative medicine and cellular longevity

Journal of cellular biochemistry

Dalton transactions (Cambridge, England : 2003)

University of Madras

Chungbuk National University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Madras

India

Assistant professor :: Department of biochemistry

Education History

Chungbuk National University

South Korea

PHD :: Department of Biotechnology

Publications

S Dharani, Giriraj Kalaiarasi, Ravi Manoharan, Sathan Raj Natarajan, Vincent M Lynch, Rathinasabapathi Prabhakaran
Diosgenin derivatives developed from Pd(II) catalysed dehydrogenative coupling exert an effect on breast cancer cells by abrogating their growth and facilitating apoptosis via regulating the AKT1 pathway. Dalton transactions (Cambridge, England : 2003) 51 (17) (2022)
Lavanya Ponnusamy, Sathan Raj Natarajan, Ravi Manoharan
MARK2 potentiate aerobic glycolysis-mediated cell growth in breast cancer through regulating mTOR/HIF-1α and p53 pathways. Journal of cellular biochemistry 123 (4) (2022)
Ravi Manoharan, Hyun-A Seong, Hyunjung Ha
Dual Roles of Serine-Threonine Kinase Receptor-Associated Protein (STRAP) in Redox-Sensitive Signaling Pathways Related to Cancer Development. Oxidative medicine and cellular longevity 2018 (2018)